The legacy success of Viagra has undeniably shaped the healthcare landscape. However, investing in companies heavily focused on copycat drugs and the waning patent rights surrounding this flagship medication presents a notable degree of peril . While leading pharma firms may still benefit from related therapies , the overall outlook for those prima

A thorough industry review is essential for grasping the current trends at play. This exploration delves into key factors influencing the contested arena, from emerging technologies and changing consumer tastes to legal hurdles and monetary uncertainties. We’ll scrutinize the general perspective, including likely growth areas, threats to current